<DOC>
	<DOC>NCT00683657</DOC>
	<brief_summary>This protocol will compare 24 hour glucose control for subject taking saxagliptin and metformin extended release (XR) versus metformin XR alone</brief_summary>
	<brief_title>Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>≥18 and ≤77yearsold Type 2 diabetes Taking metformin immediate release (IR) or XR ≥1500 mg for at least 8 weeks as monotherapy Glycosylated hemoglobin (A1C) ≥7% and ≤10% Body mass index (BMI) ≤40 kg/m2 Women of childbearing potential unable or unwilling to use acceptable birth control Women who are pregnant or breastfeeding Significant cardiovascular history Active liver disease Renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>